कंपनी का अवलोकन
Bonk, Inc. operates primarily within the Financial Services sector, specifically focusing on the Asset Management industry, yet its operational scope extends to providing over-the-counter consumer products in the United States. The company's product portfolio includes Safety Shot Beverage, a formulation designed to lower blood alcohol content, alongside various health and wellness solutions such as hair loss treatments, vitiligo solutions, eczema creams, and sexual wellness products. In terms of scale, the enterprise holds a market capitalization of $19.22M and generated annual revenue of $3.93M over the trailing twelve months, with employee count data currently unavailable. These valuation and revenue figures indicate that Bonk, Inc. occupies a niche position in the market, characterized by a relatively small market cap that suggests a micro-cap status rather than a large-cap industrial or financial institution.
वित्तीय स्वास्थ्य
The company reported a revenue of $3.93M for the trailing twelve months, while simultaneously posting a net income of $-69,049,160 and an EBITDA of $-33,833,072, revealing a significant divergence between top-line sales and bottom-line profitability. The substantial gap between the positive revenue of $3.93M and the negative net income highlights an extremely aggressive cost structure where operating expenses far exceed gross profits. Free cash flow stands at $-7,129,403, which indicates a negative liquidity position where the company is consuming cash reserves to fund operations or expansion. Analyzing the margin structure, the gross margin is 31.5%, suggesting that the company retains a moderate portion of revenue after direct costs, yet this is insufficient to cover overheads given the operating margin of -444.5%. The profit margin is recorded at 0.0%, reflecting the total erosion of earnings before tax, interest, and other non-operating items. Regarding balance sheet composition, the company holds $2.39M in cash against $347,754 in debt, resulting in a debt-to-equity ratio of 0.99. Although the company is technically net cash positive with cash exceeding debt, the high leverage ratio relative to equity suggests a capital structure that is not overly conservative. The current ratio is 1.01, which indicates that the company's short-term assets barely cover its short-term liabilities, signaling tight liquidity conditions. Furthermore, the return on equity is -415.5% and the return on assets is -89.2%, metrics that reveal management is currently destroying shareholder value and failing to generate returns on the capital deployed.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is listed as N/A due to the negative earnings, while the forward P/E is also N/A, implying that the market cannot value the stock based on traditional earnings multiples without speculative assumptions about future profitability. The price-to-book ratio is 0.16, indicating that the stock is trading at a significant discount to its book value, which often suggests a distressed asset or a market that has heavily penalized the company's prospects. Alternative valuation metrics provide further context, with a price-to-sales ratio of 4.89 and an EV/EBITDA of -0.52, suggesting the market is pricing the company based on revenue potential rather than earnings power. The 52-week high is $46.90 and the 52-week low is $2.29, meaning the current trading price sits well below the recent peak but remains significantly above the yearly floor. The beta value is 2.16, which indicates that the stock price is highly volatile and is expected to move with more than twice the magnitude of the broader market.
Growth & Income
Revenue growth year-over-year is an impressive 898.3%, driven likely by the expansion of its consumer product lines, whereas earnings growth is N/A due to the consistent net losses incurred during this period. This disparity implies that the company is prioritizing rapid top-line expansion over immediate profitability, a common strategy in growth-stage companies but one that carries inherent financial risk. As a non-dividend payer, the company does not distribute income to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests all of its remaining cash flows, however limited, back into business operations rather than paying dividends. The overall growth and income profile presents a high-risk, high-revenue-growth narrative with zero current income generation and significant operational losses.